A safety analysis of oral prednisone as a pretreatment for rituximab in rheumatoid arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A safety analysis of oral prednisone as a pretreatment for rituximab in rheumatoid arthritis

Published:2012-08-26 Issue:11 Volume:31 Page:1605-1610
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Carter J. D.,Zarabadi S. A.,Ricca L. R.,McNeil A.,Valeriano-Marcet J.,Vasey F. B.,Sebba A. I.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-012-2059-4.pdf

Reference12 articles.

1. Edwards J, Szczepanski L, Szechinski J, Filiowicz-Sosnowska A, Emery P, Close D, Stevens R, Shaw T (2004) Efficacy B-cell-targeted therapy with Rituximab in patients with rheumatoid arthritis. N Engl J Med 350:2572–2581

2. Emery P, Fleischmann R, Filiowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A, Racewicz J, van Vollenhoven R, Li N, Agarwal S, Hessey E, Shaw T (2006) The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis Rheum 54(5):1390–1400

3. Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC et al (2006) Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 54(9):2793–2806

4. Rituxan [package insert] (2011). Biogen Idec, Inc. and Genentech, Inc., South San Francisco; April 2011.

5. Mager DE, Lin SX, Blum RA, Lates CD, Jusko WJ (2003) Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics. J Clin Pharm 43:1216–1227

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of external control arms in immune-mediated inflammatory diseases: a systematic review;BMJ Open;2023-12

2. Lessons for rituximab therapy in patients with rheumatoid arthritis;The Lancet Rheumatology;2020-08

3. Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis;ACR Open Rheumatology;2020-04-21

4. Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registries;Rheumatology;2017-11-14

5. B-cell depletion;Rheumatology;2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3